Align Technology, Inc. reported first quarter 2025 total revenues of $979.3 million on April 30, 2025, a decrease of 1.8% year-over-year and 1.6% sequentially, aligning with its outlook. Clear Aligner revenues were $796.8 million, down 2.5% year-over-year, impacted by lower average selling prices and unfavorable foreign exchange.
Despite the revenue decline, Clear Aligner volume showed resilience, increasing 6.2% year-over-year to 642.3 thousand cases, with teen and growing patient volume particularly strong, up 13.3% year-over-year. Non-GAAP diluted earnings per share (EPS) for the quarter were $2.13, surpassing analyst estimates of $1.98. The company also celebrated reaching the 20 million Invisalign patient 'smilestone'.
For Q2 2025, Align projects revenues in the range of $1.05 billion to $1.07 billion, indicating sequential growth. The full fiscal year 2025 outlook anticipates total revenue growth of 3.5% to 5.5% year-over-year and mid-single-digit Clear Aligner volume growth, despite expected year-over-year declines in Clear Aligner ASPs.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.